A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches
PHASE1CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
May 31, 2014
Primary Completion Date
August 31, 2014
Study Completion Date
August 31, 2014
Conditions
Pain
Interventions
DRUG
Second generation BTDS patch
DRUG
First generation BuTrans patch
Trial Locations (1)
Unknown
Quotient Clinical Ltd, Nottingham
All Listed Sponsors
lead
Mundipharma Research Limited
INDUSTRY
NCT02160067 - A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches | Biotech Hunter | Biotech Hunter